Most reproductive hormones people are familiar with, such as estrogen and progesterone, are produced by the ovaries under instruction from the pituitary gland. HCG is different. It is secreted by the syncytiotrophoblast, the outer layer of cells of the developing embryo that will go on to form the placenta, beginning within days of implantation.
That timing matters. Because hCG comes directly from pregnancy tissue rather than from maternal glands, its presence in blood or urine is effectively a direct chemical signal that implantation has occurred, which is why it became the natural target for pregnancy detection rather than any other reproductive hormone.
In a menstrual cycle without conception, the corpus luteum, a temporary structure left behind in the ovary after ovulation, breaks down after roughly two weeks. Progesterone output falls, the uterine lining is no longer supported, and menstruation follows.
When implantation happens, rising hCG intervenes in that process. It binds the same receptor that luteinizing hormone uses and instructs the corpus luteum to keep producing progesterone rather than degrade, which keeps the uterine lining intact long enough for the pregnancy to become established.
In documented clinical literature, hCG concentrations climb quickly in the first weeks after implantation before reaching a peak around the end of the first trimester. After that peak, levels decline and settle into a lower plateau that persists for the remainder of the pregnancy.
This rise-and-plateau curve is well characterized in the medical literature and is one of the reasons a single hCG reading is rarely used on its own in a clinical setting. Clinicians are usually more interested in the trend across repeat measurements than any isolated number, a theme explored further in our article on monitoring pregnancy with beta-hCG.
This same rise-and-plateau curve is also loosely associated with how far along a pregnancy is, though ultrasound dating is considered far more reliable once it becomes available a few weeks later. In the earliest window, before an ultrasound can meaningfully visualize the pregnancy, hCG trends remain one of the only practical tools clinicians have for gauging how things are progressing.
HCG belongs to a small family of glycoprotein hormones that also includes luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone. All four share an identical alpha subunit; what makes each hormone unique is its distinct beta subunit, a distinction covered in more depth in our article on hCG alpha and beta subunits.
HCG also carries more carbohydrate side chains than luteinizing hormone, and that heavier glycosylation gives it a considerably longer half-life in the bloodstream. That biochemical detail is a large part of why hCG functions as such a stable, reliable signal in early pregnancy compared with the shorter-lived hormones it is structurally related to.
Because this rise in hCG is so predictable, it became the basis for pregnancy testing methods that are covered in our history article on pregnancy testing, from early animal bioassays through to modern digital home tests.
This article is provided for general educational purposes. REVIVE LAB UAE supplies non-prescription research peptides for laboratory and research use and does not sell, stock, or supply hCG in any form.